Molly Gale

599 total citations
8 papers, 355 citations indexed

About

Molly Gale is a scholar working on Molecular Biology, Organic Chemistry and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Molly Gale has authored 8 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 1 paper in Organic Chemistry and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Molly Gale's work include Cancer-related gene regulation (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and Epigenetics and DNA Methylation (3 papers). Molly Gale is often cited by papers focused on Cancer-related gene regulation (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and Epigenetics and DNA Methylation (3 papers). Molly Gale collaborates with scholars based in United States, China and Canada. Molly Gale's co-authors include Qin Yan, Jian Cao, Lizhen Wu, Wesley L. Cai, Shang‐Min Zhang, William K.C. Cheung, Qi Xu, Min Lu, Daniël Hoyer and Jane S. Merkel and has published in prestigious journals such as Nucleic Acids Research, Blood and PLoS ONE.

In The Last Decade

Molly Gale

8 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Molly Gale United States 6 308 75 53 41 36 8 355
Suet‐Yan Kwan United States 7 378 1.2× 56 0.7× 43 0.8× 28 0.7× 46 1.3× 9 474
Wesley L. Cai United States 8 321 1.0× 104 1.4× 43 0.8× 53 1.3× 36 1.0× 19 420
Rodrigo Romero United States 5 309 1.0× 97 1.3× 55 1.0× 37 0.9× 80 2.2× 9 373
Svenja Leible Germany 7 366 1.2× 88 1.2× 64 1.2× 44 1.1× 48 1.3× 10 509
Wipawadee Grernrum Netherlands 4 384 1.2× 91 1.2× 56 1.1× 22 0.5× 41 1.1× 4 430
Marion Piganeau France 5 474 1.5× 69 0.9× 61 1.2× 16 0.4× 95 2.6× 6 506
Sasha Pantel United States 4 303 1.0× 65 0.9× 29 0.5× 14 0.3× 82 2.3× 4 336
Jianting Mao China 7 312 1.0× 70 0.9× 124 2.3× 39 1.0× 38 1.1× 10 405
Charles C. Bell Australia 9 301 1.0× 49 0.7× 63 1.2× 16 0.4× 50 1.4× 12 395
Li-Juan Ji China 9 413 1.3× 53 0.7× 212 4.0× 42 1.0× 54 1.5× 10 495

Countries citing papers authored by Molly Gale

Since Specialization
Citations

This map shows the geographic impact of Molly Gale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molly Gale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molly Gale more than expected).

Fields of papers citing papers by Molly Gale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Molly Gale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Molly Gale. The network helps show where Molly Gale may publish in the future.

Co-authorship network of co-authors of Molly Gale

This figure shows the co-authorship network connecting the top 25 collaborators of Molly Gale. A scholar is included among the top collaborators of Molly Gale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Molly Gale. Molly Gale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Gale, Molly, Yao Li, Jian Cao, et al.. (2019). Acquired Resistance to HER2-Targeted Therapies Creates Vulnerability to ATP Synthase Inhibition. Cancer Research. 80(3). 524–535. 36 indexed citations
2.
Cao, Jian, Lizhen Wu, Shang‐Min Zhang, et al.. (2016). An easy and efficient inducible CRISPR/Cas9 platform with improved specificity for multiple gene targeting. Nucleic Acids Research. 44(19). gkw660–gkw660. 165 indexed citations
3.
Gale, Molly, Joyce Sayegh, Jian Cao, et al.. (2016). Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance. Oncotarget. 7(26). 39931–39944. 64 indexed citations
4.
Gale, Molly & Qin Yan. (2015). High-throughput screening to identify inhibitors of lysine demethylases. Epigenomics. 7(1). 57–65. 15 indexed citations
5.
Pirazzoli, Valentina, Caroline A. Nebhan, Xiaoling Song, et al.. (2014). Acquired Resistance of EGFR-Mutant Lung Adenocarcinomas to Afatinib plus Cetuximab Is Associated with Activation of mTORC1. Cell Reports. 7(4). 999–1008. 56 indexed citations
6.
LoBello, Janine, Molly Gale, Aprill Watanabe, et al.. (2012). The Role of the Histone Demethyltransferase Gene JMJD1C and H3K9 Methylation in Multiple Myeloma. Blood. 120(21). 3527–3527. 1 indexed citations
7.
Jung, Sungwon, et al.. (2012). DNA Methylation in Multiple Myeloma Is Weakly Associated with Gene Transcription. Blood. 120(21). 1285–1285. 1 indexed citations
8.
Jung, Sungwon, Seungchan Kim, Molly Gale, et al.. (2012). DNA Methylation in Multiple Myeloma Is Weakly Associated with Gene Transcription. PLoS ONE. 7(12). e52626–e52626. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026